EE200100656A - Kristallilise asabitsüklo(2,2,2)oktaan-3-amiintsitraadi polümorfid ja nende ravimsegud - Google Patents

Kristallilise asabitsüklo(2,2,2)oktaan-3-amiintsitraadi polümorfid ja nende ravimsegud

Info

Publication number
EE200100656A
EE200100656A EEP200100656A EEP200100656A EE200100656A EE 200100656 A EE200100656 A EE 200100656A EE P200100656 A EEP200100656 A EE P200100656A EE P200100656 A EEP200100656 A EE P200100656A EE 200100656 A EE200100656 A EE 200100656A
Authority
EE
Estonia
Prior art keywords
crystalline
octane
mixtures
azabicyclo
polymorphs
Prior art date
Application number
EEP200100656A
Other languages
English (en)
Estonian (et)
Inventor
James Castaldi Michael
Joseph Quallich George
Theophilus Wint Lewin
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of EE200100656A publication Critical patent/EE200100656A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200100656A 1999-06-01 2000-05-18 Kristallilise asabitsüklo(2,2,2)oktaan-3-amiintsitraadi polümorfid ja nende ravimsegud EE200100656A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01
PCT/IB2000/000665 WO2000073304A1 (en) 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions

Publications (1)

Publication Number Publication Date
EE200100656A true EE200100656A (et) 2003-02-17

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100656A EE200100656A (et) 1999-06-01 2000-05-18 Kristallilise asabitsüklo(2,2,2)oktaan-3-amiintsitraadi polümorfid ja nende ravimsegud

Country Status (49)

Country Link
US (1) US6255320B1 (xx)
EP (1) EP1181290B1 (xx)
JP (1) JP3830816B2 (xx)
KR (1) KR100476606B1 (xx)
CN (1) CN1146565C (xx)
AP (1) AP2001002349A0 (xx)
AR (1) AR033331A1 (xx)
AT (1) ATE244239T1 (xx)
AU (1) AU767334B2 (xx)
BG (1) BG65240B1 (xx)
BR (1) BR0011094A (xx)
CA (1) CA2372238C (xx)
CO (1) CO5170463A1 (xx)
CY (1) CY2007011I1 (xx)
CZ (1) CZ295819B6 (xx)
DE (1) DE60003679T2 (xx)
DK (1) DK1181290T3 (xx)
DZ (1) DZ3050A1 (xx)
EA (1) EA003731B1 (xx)
EC (1) ECSP003508A (xx)
EE (1) EE200100656A (xx)
ES (1) ES2199825T3 (xx)
GT (1) GT200000087A (xx)
HK (1) HK1046284A1 (xx)
HN (1) HN2000000077A (xx)
HR (1) HRP20010904A2 (xx)
HU (1) HUP0201301A3 (xx)
IL (1) IL146406A0 (xx)
MA (1) MA26742A1 (xx)
MX (1) MXPA01012325A (xx)
MY (1) MY133508A (xx)
NO (1) NO20015848L (xx)
NZ (1) NZ515349A (xx)
OA (1) OA11956A (xx)
PA (1) PA8496101A1 (xx)
PE (1) PE20010209A1 (xx)
PL (1) PL196046B1 (xx)
PT (1) PT1181290E (xx)
SI (1) SI1181290T1 (xx)
SK (1) SK285820B6 (xx)
SV (1) SV2001000093A (xx)
TN (1) TNSN00120A1 (xx)
TR (1) TR200103473T2 (xx)
TW (1) TWI285204B (xx)
UA (1) UA66925C2 (xx)
UY (1) UY26176A1 (xx)
WO (1) WO2000073304A1 (xx)
YU (1) YU81101A (xx)
ZA (1) ZA200109775B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005216707A1 (en) * 2004-01-30 2005-09-09 Pfizer Products Inc. Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
US8183230B2 (en) * 2004-01-30 2012-05-22 Pfizer Inc. Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
MXPA06007964A (es) * 2004-01-30 2007-01-26 Pfizer Prod Inc Antagonistas del receptor nk-1 para mejorar la recuperacion de anestesia.
DE602005003791T2 (de) * 2004-02-02 2008-05-29 Pfizer Products Inc., Groton Verfahren zur herstellung von 1-(2s,3s)-2-benzhydril-n-(5-tert.-butyl-2-methoxybenzyl)chinuklidin-3-amin
RU2696582C2 (ru) * 2013-03-15 2019-08-05 Перл Терапьютикс, Инк. Способы и системы кондиционирования дисперсных кристаллических материалов
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL171379B1 (en) * 1991-05-31 1997-04-30 Pfizer Method of obtaining novel derivatives of quinuclidine
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
EP1181290B1 (en) 2003-07-02
CA2372238A1 (en) 2000-12-07
PL196046B1 (pl) 2007-11-30
ES2199825T3 (es) 2004-03-01
NZ515349A (en) 2004-03-26
SV2001000093A (es) 2001-11-08
EA003731B1 (ru) 2003-08-28
GT200000087A (es) 2001-11-22
KR20020010688A (ko) 2002-02-04
AR033331A1 (es) 2003-12-17
ZA200109775B (en) 2002-11-28
BG106204A (en) 2002-07-31
AU4424800A (en) 2000-12-18
CY2007011I2 (el) 2010-07-28
EP1181290A1 (en) 2002-02-27
CN1146565C (zh) 2004-04-21
DK1181290T3 (da) 2003-09-29
MY133508A (en) 2007-11-30
TR200103473T2 (tr) 2002-04-22
WO2000073304A1 (en) 2000-12-07
SI1181290T1 (en) 2003-12-31
NO20015848D0 (no) 2001-11-30
CY2007011I1 (el) 2010-07-28
CZ295819B6 (cs) 2005-11-16
IL146406A0 (en) 2002-07-25
HK1046284A1 (en) 2003-01-03
BG65240B1 (bg) 2007-09-28
SK285820B6 (sk) 2007-09-06
CO5170463A1 (es) 2002-06-27
BR0011094A (pt) 2002-03-19
OA11956A (en) 2006-04-13
PE20010209A1 (es) 2001-03-01
HUP0201301A3 (en) 2002-10-28
AU767334B2 (en) 2003-11-06
DE60003679T2 (de) 2004-05-27
CA2372238C (en) 2006-12-19
JP3830816B2 (ja) 2006-10-11
HN2000000077A (es) 2001-02-02
AP2001002349A0 (en) 2001-12-31
PA8496101A1 (es) 2002-07-30
HRP20010904A2 (en) 2003-02-28
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
SK17332001A3 (sk) 2002-07-02
PL352716A1 (en) 2003-09-08
MXPA01012325A (es) 2002-07-22
DE60003679D1 (de) 2003-08-07
CN1353711A (zh) 2002-06-12
KR100476606B1 (ko) 2005-03-18
TWI285204B (en) 2007-08-11
HUP0201301A2 (en) 2002-08-28
UY26176A1 (es) 2000-12-29
DZ3050A1 (fr) 2004-03-27
TNSN00120A1 (fr) 2005-11-10
JP2003501354A (ja) 2003-01-14
UA66925C2 (uk) 2004-06-15
YU81101A (sh) 2004-07-15
CZ20014269A3 (cs) 2002-04-17
EA200101108A1 (ru) 2002-04-25
PT1181290E (pt) 2003-09-30
MA26742A1 (fr) 2004-12-20
ATE244239T1 (de) 2003-07-15
ECSP003508A (es) 2002-02-25

Similar Documents

Publication Publication Date Title
NO20021382L (no) Fremgangsmåter og mikroorganismer for fremstilling av panto- forbindelser
FI20010154A (fi) Menetelmä citalopramin valmistamiseksi
EE200100574A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
EE200200281A (et) Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
ID28601A (id) Proses penyiapan senyawa-senyawa 1,4-dihidropiridin
NO20003454L (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO993949L (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
EE200100656A (et) Kristallilise asabitsüklo(2,2,2)oktaan-3-amiintsitraadi polümorfid ja nende ravimsegud
NO20001909L (no) FremgangsmÕte og anlegg for fremstilling av 1,2-dikloretan
EE200100573A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
NO20000456D0 (no) Fremgangsmåte for fremstilling av 1,2-dikloretan
IS6159A (is) Fjölgervingar af kristölluðu asabísýkló (2,2,2) oktan-3-amín sítrati og lyfjasamsetningar
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
EE200000752A (et) Alfa-D-ksüloosiühendid, nende valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon
NO20000965L (no) FremgangsmÕte for fremstilling av veksthormon-utskillende forbindelser
NO20014383L (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
NO20000805L (no) FremgangsmÕte for fremstilling av organiske azider
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20013044L (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20005818L (no) Forbedret fremgangsmåte for fremstilling av farmasöytisk verdifulle norbenzomorfan-derivater
NO20005856L (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol